Alpha Teknova, Inc. Common Stock (TKNO) is a publicly traded Healthcare sector company. As of November 4, 2026, TKNO trades at $7.35 with a market cap of $452.90M and a P/E ratio of -28.95. TKNO moved +0.41% today. Year to date, TKNO is +83.67%; over the trailing twelve months it is +54.67%. Its 52-week range spans $1.91 to $9.48. Analyst consensus is strong buy with an average price target of $9.50. Rallies surfaces TKNO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Teknova Q3 revenue rose 22%; public offering raised $46 million: Teknova’s third-quarter revenue rose 22% year over year to $12.7 million, and its net loss narrowed 19% to $3.49 million. It raised FY26 revenue guidance to $46 million–$48 million, and an October 22 public offering raised $46 million in gross proceeds.
| Metric | Value |
|---|---|
| Price | $7.35 |
| Market Cap | $452.90M |
| P/E Ratio | -28.95 |
| EPS | $-0.31 |
| Dividend Yield | 0.00% |
| 52-Week High | $9.48 |
| 52-Week Low | $1.91 |
| Volume | 315.95K |
| Avg Volume | 0 |
| Revenue (TTM) | $43.70M |
| Net Income | $-16.77M |
| Gross Margin | 34.60% |
7 analysts cover TKNO: 0 strong buy, 6 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.50.